Research advances in heparin-induced thrombocytopenia
10.3969/j.issn.1008-794X.2017.05.001
- VernacularTitle:肝素诱导性血小板减少症相关研究进展
- Author:
Peilei ZHANG
;
Geng ZHOU
;
Yongde CHENG
- Keywords:
heparin-induced thrombocytopenia;
epidemiology;
clinical evaluation;
therapy;
endovascular intervention
- From:
Journal of Interventional Radiology
2017;26(5):385-389
- CountryChina
- Language:Chinese
-
Abstract:
Clinically,heparin-induced thrombocytopenia (HIT) is an uncommon but serious disease,which is induced by the use of immune unfractionated heparin or low-molecular-weight heparin.The overall incidence of HIT is about 0.6％-5.0％.Nevertheless,in clinical practice it is profoundly dangerous,especially for patients who are receiving cardiovascular surgery or interventional therapy.At present,HIT is a hot clinical research subject.This paper aims to make a brief review about HIT pathogenesis,epidemiology,clinical evaluation and treatment,etc.
